Plateaus and when to escalate A plateau is typically defined as less than one percent of body weight lost over a four to six week period while adhering to the protocol
Take medicines that make it harder to lose weight Hormonal imbalances can change how the body can lose weight and slow down weight loss
Although tiredness is not always listed as the main headline
Medical Eligibility Required Semaglutide and Tirzepatide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Tirzepatide or Semaglutide
A modest increase in heart rate of a few beats per minute was also noted, consistent with a known class effect of GLP-1 receptor agonists
Peptide Therapy Peptide treatments offer targeted metabolic support for fat loss, energy, muscle tone, and appetite regulation